On the history, synthesis, and medicinal use of cantharidin, LB-100, and their analogs.

RSC Med Chem · 2026 · PMC12772682 · PMID 41502824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

As such, there may be significant potential for using cantharidin derivatives to target these enzymes in much the same way that LB-100 has for PP2A, though this will require new chemistries to access C1/C2 substituted analogs.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.